{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:34:30Z","timestamp":1794674070160,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.vaccine.2025.127304","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:03:48Z","timestamp":1748462628000},"page":"127304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immune persistence after 5\u00a0years of vaccination by Vi-DT vaccine among children below 2\u00a0years: Result from long-term observational study"],"prefix":"10.1016","volume":"60","author":[{"given":"Rejwana Haque","family":"Pial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosario","family":"Capeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina Rok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Lyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh Reddy","family":"Eluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Kyoung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hwa","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Keun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Sahastrabuddhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.vaccine.2025.127304_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"issue":"68","key":"10.1016\/j.vaccine.2025.127304_bb0010","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/ciy846","article-title":"Progress in typhoid fever epidemiology","volume":"15","author":"Crump","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127304_bb0015","article-title":"Enteric fever: diagnostic challenges and the importance of early intervention","author":"Saha","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127304_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the global burden of disease study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127304_bb0025","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1016\/S2666-5247(22)00093-3","article-title":"The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study","volume":"3","author":"da Silva","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2025.127304_bb0030","series-title":"Emergence of an extensively drug-resistant Salmonella Enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","author":"Klemm","year":"2018"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127304_bb0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3855\/jidc.3817","article-title":"A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi a in Pakistan","volume":"8","author":"Qamar","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127304_bb0040","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/cid\/ciy386","article-title":"Determining the best immunization strategy for protecting African children against invasive Salmonella disease","volume":"67","author":"Jeon","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127304_bb0045","series-title":"The lancet infectious diseases","first-page":"340","article-title":"The global burden of enteric fevers in the age of typhoid-conjugate vaccines","volume":"vol. 19","author":"Wierzba","year":"2019"},{"key":"10.1016\/j.vaccine.2025.127304_bb0050","series-title":"Vaccines for preventing typhoid fever","volume":"vol. 2014","author":"Anwar","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127304_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00434-8","article-title":"Immune persistence and response to booster dose of vi-DT vaccine at 27.5 months post-first dose","volume":"7","author":"Capeding","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127304_bb0060","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a vi-DT typhoid conjugate vaccine: phase I trial in healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127304_bb0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127304_bb0070","article-title":"Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)","volume":"2023","author":"Gloeck","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.127304_bb0075","first-page":"27","article-title":"Safety and immunogenicity of vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study","volume":"1","author":"Capeding","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127304_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(21)00455-2","article-title":"Safety and immunogenicity of the vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial","volume":"22","author":"Kumar Rai","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2025.127304_bb0085","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.vaccine.2019.09.074","article-title":"Immunogenicity, safety and reactogenicity of a phase II trial of vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: a preliminary report","volume":"38","author":"Capeding","year":"2020","journal-title":"Vaccine"},{"issue":"10301","key":"10.1016\/j.vaccine.2025.127304_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"issue":"10425","key":"10.1016\/j.vaccine.2025.127304_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","article-title":"Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children","volume":"403","author":"Patel","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127304_bb0100","series-title":"WHO position paper Typhoid vaccine","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127304_bb0105","series-title":"Clinical infectious diseases","first-page":"393","article-title":"Safety and immunogenicity of a vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: A multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"vol. 61","author":"Mohan","year":"2015"},{"issue":"61","key":"10.1016\/j.vaccine.2025.127304_bb0110","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1093\/cid\/civ709","article-title":"A perspective on invasive salmonella disease in Africa","volume":"1","author":"Crump","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127304_bb0115","article-title":"The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in Kathmandu","volume":"7","author":"Dongol","year":"2012","journal-title":"Nepal PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127304_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001998","article-title":"Typhoid fever and its association with environmental factors in the Dhaka metropolitan area of Bangladesh: a spatial and time-series approach","volume":"7","author":"Dewan","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127304_bb0125","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.05.020407","article-title":"Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever","volume":"5","author":"Azmatullah","year":"2015","journal-title":"J Glob Health"},{"issue":"218","key":"10.1016\/j.vaccine.2025.127304_bb0130","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/infdis\/jix598","article-title":"Comparison of strategies and incidence thresholds for VI conjugate vaccines against typhoid fever: a cost-effectiveness modeling study","volume":"10","author":"Lo","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127304_bb0135","series-title":"Vaccines for preventing typhoid fever","volume":"vol. 2018","author":"Milligan","year":"2018"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127304_bb0140","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to vi polysaccharide\u2013tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7\u00a0years following primary vaccination of children\u00a0<\u00a02\u00a0years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127304_bb0145","series-title":"Typhoid fever vaccination strategies","first-page":"C55","volume":"vol. 33","author":"Date","year":"2015"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127304_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(24)00079-2","article-title":"Onsare RS. High burden of typhoid disease in sub-Saharan Africa calls for urgent roll-out of typhoid conjugate vaccines","volume":"12","author":"Kariuki","year":"2024","journal-title":"Lancet Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:19:01Z","timestamp":1749107941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"alternative-id":["S0264410X25006012"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127304","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune persistence after 5\u00a0years of vaccination by Vi-DT vaccine among children below 2\u00a0years: Result from long-term observational study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Vaccine Institute. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127304"}}